ADC Therapeutics (ADCT) Insider Trading & Ownership $1.64 -0.04 (-2.10%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.64 0.00 (0.00%) As of 02/21/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ADC Therapeutics (NYSE:ADCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$1.43 MNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$205,889.07 Get ADCT Insider Trade Alerts Want to know when executives and insiders are buying or selling ADC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADCT Insider Buying and Selling by Quarter ADC Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/11/2024Redmile Group, LlcMajor ShareholderBuy100,000$3.04$304,000.00 12/4/2024Redmile Group, LlcMajor ShareholderSell25,352$2.07$52,478.64 7/1/2024Redmile Group, LlcMajor ShareholderBuy400,000$2.81$1,124,000.00 6/17/2024Robert AzelbyDirectorSell6,995$2.89$20,215.55 5/7/2024Ameet MallikCEOSell29,731$4.48$133,194.88 (Data available from 1/1/2013 forward) ADCT Insider Trading Activity - Frequently Asked Questions Who is on ADC Therapeutics's Insider Roster? The list of insiders at ADC Therapeutics includes Ameet Mallik, Redmile Group, Llc, and Robert Azelby. Learn more on insiders at ADCT. What percentage of ADC Therapeutics stock is owned by insiders? 4.10% of ADC Therapeutics stock is owned by insiders. Learn more on ADCT's insider holdings. Which ADC Therapeutics insiders have been buying company stock? The following insider purchased ADCT shares in the last 24 months: Redmile Group, Llc ($1,428,000.00). How much insider buying is happening at ADC Therapeutics? Insiders have purchased a total of 500,000 ADCT shares in the last 24 months for a total of $1,428,000.00 bought. Which ADC Therapeutics insiders have been selling company stock? The following insiders have sold ADCT shares in the last 24 months: Ameet Mallik ($133,194.88), Redmile Group, Llc ($52,478.64), and Robert Azelby ($20,215.55). How much insider selling is happening at ADC Therapeutics? Insiders have sold a total of 62,078 ADC Therapeutics shares in the last 24 months for a total of $205,889.07 sold. ADC Therapeutics Key ExecutivesDr. Ameet Mallik M.B.A. (Age 51)M.S., CEO & Director Compensation: $1.84MMr. Jose I. Carmona M.B.A. (Age 52)Chief Financial Officer Compensation: $884.86kDr. Mohamed Zaki M.D. (Age 59)Ph.D., Chief Medical Officer Compensation: $2.41MMs. Lisa Michelle KalleboCorporate Controller & Chief Accounting OfficerDr. Michael Mulkerrin Ph.D. (Age 69)Chief Technical Operations Officer Dr. Patrick van Berkel Ph.D. (Age 56)Chief Scientific Officer Amanda HamiltonInvestor Relations OfficerMr. Peter J. Graham Esq. (Age 57)Chief Legal Officer Ms. Eugenia LitzVice President of Investor Relations & Corporate CommunicationsMs. Kimberly Pope (Age 57)Senior VP & Chief People Officer More Insider Trading Tools from MarketBeat Related Companies ORIC Insider Selling RAPP Insider Selling SEPN Insider Selling PGEN Insider Selling STOK Insider Selling CGEM Insider Selling XERS Insider Selling TECX Insider Selling MGTX Insider Selling MLYS Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NYSE:ADCT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 financial crisis over a year in advance. His readers had a chance to lock in g...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADC Therapeutics SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ADC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
